Point72 Asset Management, L.P. 13D and 13G filings for Janux Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-04-29 5:31 pm Unchanged | 2026-04-28 | 13G | JANUX THERAPEUTICS INC JANX | Point72 Asset Management, L.P. | 3,069,759 5.000% | 0 (Unchanged) | Filing |
| 2026-04-29 5:30 pm Purchase | 2026-04-28 | 13G | JANUX THERAPEUTICS INC JANX | Point72 Asset Management, L.P. | 3,069,759 5.000% | 3,069,759 (New Position) | Filing |